Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment

Extending a structural model of somatization to South Koreans: Cultural values, somatization tendency, and the presentation of depressive symptoms

(2015) Xiaolu Zhou et al.   JOURNAL OF AFFECTIVE DISORDERS

Application Feasibility of Antioxidant Activity Evaluation Using Potentiometry in Major Depressive Disorder

(2014) Gyoung-Ja LEE et al.   ELECTROCHEMISTRY

Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment

(2014) Piotr Gałecki et al.   Pharmacological Reports

Antioxidants as Antidepressants

(2012) Giovanni Scapagnini et al.   CNS DRUGS

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

(2012) Seung-Yup Lee et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study

(2011) Vahap Ozan Kotan et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

(2010) Jeremy W. Gawryluk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

(2010) Michael Maes et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment

(2009) Birgul Elbozan Cumurcu et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Major Depressive Disorder

(2008) R.H. Belmaker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glutathione: a novel treatment target in psychiatry

(2008) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES